BURLINGAME, Calif., Sept. 11, 2019 /PRNewswire/ -- Color open-sources a playbook that provides the underlying framework for its Population Genomics Platform. The playbook is available to organizations working to build and scale population genomics programs. By open-sourcing this playbook, Color is supporting global efforts to make genetics and precision health programs accessible, convenient, and c

STOCKHOLM, Sept. 11, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that clinical trial data were presented at the Society of Hematologic Oncology (SOHO) 2019 Annual Meeting in Houston, TX, USA. In an oral presentation, data from the pivotal Phase 2 HORIZON clinical trial were presented as part of the meeting's multip

WASHINGTON, Sept. 11, 2019 /PRNewswire/ -- President Trump's announcement that the government will remove flavored e-cigarettes from the market is a necessary and long-overdue step to address the epidemic of youth e-cigarette use in the United States, but it must be comprehensive, immediate and long-lasting. This is a public health crisis

NASHVILLE, Tenn., Sept. 11, 2019 /PRNewswire/ -- SmileDirectClub, Inc., the industry pioneer and first direct-to-consumer medtech platform for transforming smiles, today announced the pricing of its initial public offering of 58,537,000 shares of its Class A common stock at a price to the public of $23.00 per share. SmileDirectClub has

ALHAMBRA, Calif., Sept. 11, 2019 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, today announced that it has closed a new credit facility. The new aggregate $290 million credit facility consists of a $190 million sen

CONCORD, Mass., Sept. 11, 2019 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation

WASHINGTON, Sept. 11, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients, commends the U.S. Environmental Protection Agency (EPA) for yesterday's pledge "to aggressively redu

PHOENIX, Sept. 11, 2019 /PRNewswire/ -- Blue Cross Blue Shield of Arizona (BCBSAZ) and fitness icon Jake "Body by Jake" Steinfeld unveiled the new Get

Generates Net Revenue of $98.9 Million, Up 52% From Prior QuarterCannabis Net Revenue Increases 61% to $94.6 Million From Prior QuarterReports Gross Margin on Cannabis Net Revenue of 58%TSX: ACB | NYSE: ACB EDMONTON, Sept. 11, 201

SUZHOU and SHANGHAI, China, Sept. 11, 2019  /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced a positive continued clinical readout of a multi-center pilot study designed to evaluate the safety and efficacy of Gracell's first-in-class FasT CAR-19 (GC007F) investigational cell gene therapy. Th